Cargando…
Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia
Pericytes play a pivotal role in contraction, mediating inflammation and regulation of blood flow in the brain. In this study, changes of pericytes in the neurovascular unit (NVU) were examined in relation to the effects of exogenous tissue plasminogen activator (tPA) and a free radical scavenger, e...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263311/ https://www.ncbi.nlm.nih.gov/pubmed/24938625 http://dx.doi.org/10.1002/jnr.23420 |
_version_ | 1782348545647443968 |
---|---|
author | Deguchi, Kentaro Liu, Ning Liu, Wentao Omote, Yoshio Kono, Syoichiro Yunoki, Taijun Deguchi, Shoko Yamashita, Toru Ikeda, Yoshio Abe, Koji |
author_facet | Deguchi, Kentaro Liu, Ning Liu, Wentao Omote, Yoshio Kono, Syoichiro Yunoki, Taijun Deguchi, Shoko Yamashita, Toru Ikeda, Yoshio Abe, Koji |
author_sort | Deguchi, Kentaro |
collection | PubMed |
description | Pericytes play a pivotal role in contraction, mediating inflammation and regulation of blood flow in the brain. In this study, changes of pericytes in the neurovascular unit (NVU) were examined in relation to the effects of exogenous tissue plasminogen activator (tPA) and a free radical scavenger, edaravone. Immunohistochemistry and Western blot analyses showed that the overlap between platelet-derived growth factor receptor β-positive pericytes and N-acetylglucosamine oligomers (NAGO)-positive endothelial cells increased significantly at 4 days after 90 min of transient middle cerebral artery occlusion (tMCAO). The number of pericytes and the overlap with NAGO decreased with tPA but recovered with edaravone 4 days after tMCAO with proliferation. Thus, tPA treatment damaged pericytes, resulting in the detachment from astrocytes and a decrease in glial cell line-derived neurotrophic factor secretion. However, treatment with edaravone greatly improved tPA-induced damage to pericytes. The present study demonstrates that exogenous tPA strongly damages pericytes and destroys the integrity of the NVU, but edaravone treatment can greatly ameliorate such damage after acute cerebral ischemia in rats. © 2014 The Authors. Journal of Neuroscience Research Published by Wiley Periodicals, Inc. |
format | Online Article Text |
id | pubmed-4263311 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42633112014-12-15 Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia Deguchi, Kentaro Liu, Ning Liu, Wentao Omote, Yoshio Kono, Syoichiro Yunoki, Taijun Deguchi, Shoko Yamashita, Toru Ikeda, Yoshio Abe, Koji J Neurosci Res Research Articles Pericytes play a pivotal role in contraction, mediating inflammation and regulation of blood flow in the brain. In this study, changes of pericytes in the neurovascular unit (NVU) were examined in relation to the effects of exogenous tissue plasminogen activator (tPA) and a free radical scavenger, edaravone. Immunohistochemistry and Western blot analyses showed that the overlap between platelet-derived growth factor receptor β-positive pericytes and N-acetylglucosamine oligomers (NAGO)-positive endothelial cells increased significantly at 4 days after 90 min of transient middle cerebral artery occlusion (tMCAO). The number of pericytes and the overlap with NAGO decreased with tPA but recovered with edaravone 4 days after tMCAO with proliferation. Thus, tPA treatment damaged pericytes, resulting in the detachment from astrocytes and a decrease in glial cell line-derived neurotrophic factor secretion. However, treatment with edaravone greatly improved tPA-induced damage to pericytes. The present study demonstrates that exogenous tPA strongly damages pericytes and destroys the integrity of the NVU, but edaravone treatment can greatly ameliorate such damage after acute cerebral ischemia in rats. © 2014 The Authors. Journal of Neuroscience Research Published by Wiley Periodicals, Inc. BlackWell Publishing Ltd 2014-11 2014-06-17 /pmc/articles/PMC4263311/ /pubmed/24938625 http://dx.doi.org/10.1002/jnr.23420 Text en Copyright © 2014 The Authors. Journal of Neuroscience Research Published by Wiley Periodicals, Inc. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Deguchi, Kentaro Liu, Ning Liu, Wentao Omote, Yoshio Kono, Syoichiro Yunoki, Taijun Deguchi, Shoko Yamashita, Toru Ikeda, Yoshio Abe, Koji Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia |
title | Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia |
title_full | Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia |
title_fullStr | Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia |
title_full_unstemmed | Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia |
title_short | Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia |
title_sort | pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263311/ https://www.ncbi.nlm.nih.gov/pubmed/24938625 http://dx.doi.org/10.1002/jnr.23420 |
work_keys_str_mv | AT deguchikentaro pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia AT liuning pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia AT liuwentao pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia AT omoteyoshio pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia AT konosyoichiro pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia AT yunokitaijun pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia AT deguchishoko pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia AT yamashitatoru pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia AT ikedayoshio pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia AT abekoji pericyteprotectionbyedaravoneaftertissueplasminogenactivatortreatmentinratcerebralischemia |